Danny Hsu

785 total citations
27 papers, 510 citations indexed

About

Danny Hsu is a scholar working on Hematology, Immunology and Organic Chemistry. According to data from OpenAlex, Danny Hsu has authored 27 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in Danny Hsu's work include Complement system in diseases (5 papers), Renal Diseases and Glomerulopathies (4 papers) and Cell death mechanisms and regulation (4 papers). Danny Hsu is often cited by papers focused on Complement system in diseases (5 papers), Renal Diseases and Glomerulopathies (4 papers) and Cell death mechanisms and regulation (4 papers). Danny Hsu collaborates with scholars based in United States, Australia and Hong Kong. Danny Hsu's co-authors include Paul J. Hergenrother, Chris J. Novotny, Quinn P. Peterson, Paul R. Carlier, David R. Goode, Hong‐Wu Zhao, Diana C. West, Levent Dirikolu, Timothy M. Fan and Joanna Schmit and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Danny Hsu

24 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danny Hsu United States 12 214 184 117 50 43 27 510
Matthew Labenski United States 12 405 1.9× 200 1.1× 166 1.4× 33 0.7× 50 1.2× 20 701
Peter D. Gorycki United States 13 344 1.6× 146 0.8× 166 1.4× 29 0.6× 47 1.1× 29 735
Cunlong Zhang China 17 379 1.8× 266 1.4× 132 1.1× 25 0.5× 15 0.3× 32 641
Zilun Hu United States 11 175 0.8× 132 0.7× 144 1.2× 29 0.6× 41 1.0× 23 460
Zigao Yuan China 17 497 2.3× 138 0.8× 208 1.8× 20 0.4× 28 0.7× 36 697
Weiqiong Zuo China 14 316 1.5× 181 1.0× 78 0.7× 44 0.9× 44 1.0× 21 522
Lu Zhou China 17 314 1.5× 84 0.5× 133 1.1× 108 2.2× 16 0.4× 50 683
Youlu Pan China 14 262 1.2× 219 1.2× 122 1.0× 28 0.6× 24 0.6× 38 609
Chiara Rusconi Italy 15 123 0.6× 78 0.4× 182 1.6× 33 0.7× 101 2.3× 53 563
Christophe Henry France 12 160 0.7× 100 0.5× 158 1.4× 25 0.5× 54 1.3× 25 459

Countries citing papers authored by Danny Hsu

Since Specialization
Citations

This map shows the geographic impact of Danny Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Hsu more than expected).

Fields of papers citing papers by Danny Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Hsu. The network helps show where Danny Hsu may publish in the future.

Co-authorship network of co-authors of Danny Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Danny Hsu. A scholar is included among the top collaborators of Danny Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny Hsu. Danny Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Hee Gyung, Danny Hsu, Noritoshi Kato, et al.. (2025). Management of Atypical Haemolytic Uraemic Syndrome With Triggers: Diagnostic and Treatment Algorithms From an Asia‐Pacific Perspective. Nephrology. 30(9). e70116–e70116.
2.
3.
Noori, Tahereh, Jesse A. Rudd-Schmidt, Alisa Kane, et al.. (2023). A cell-based functional assay that accurately links genotype to phenotype in Familial HLH. Blood. 141(19). 2330–2342. 7 indexed citations
4.
Chapman, Kent, Soma Mohammed, Leonardo Pasalic, et al.. (2023). A multicenter evaluation of the Technoscreen ADAMTS13 activity semi‐quantitative screening test for thrombotic thrombocytopenic purpura diagnosis and exclusion. International Journal of Laboratory Hematology. 45(4). 562–570. 5 indexed citations
5.
6.
Cheung, Tak Hong, et al.. (2023). Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong. Human Vaccines & Immunotherapeutics. 19(2). 2184605–2184605. 9 indexed citations
7.
Choi, Philip, Danny Hsu, Huyen Tran, et al.. (2023). Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients. Research and Practice in Thrombosis and Haemostasis. 7(1). 100009–100009. 3 indexed citations
8.
Choi, Philip, Danny Hsu, Huyen Tran, et al.. (2021). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. 107(5). 1193–1196. 9 indexed citations
9.
Cheung, Tak Hong, Danny Hsu, Queenie Wing-Lei Wong, et al.. (2021). The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong. Cost Effectiveness and Resource Allocation. 19(1). 75–75. 7 indexed citations
10.
Choi, Philip, Eileen Merriman, Anoop Enjeti, et al.. (2021). Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. The Medical Journal of Australia. 216(1). 43–52. 12 indexed citations
11.
Yuen, Man‐Fung, Wai‐Kay Seto, Lung‐Yi Mak, et al.. (2020). Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong. Digestive Diseases and Sciences. 66(4). 1315–1326. 6 indexed citations
12.
Hsu, Danny, et al.. (2020). A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab. BMC Nephrology. 21(1). 488–488. 3 indexed citations
13.
Loong, Herbert H., Carlos King Ho Wong, Praveen Dhankhar, et al.. (2019). Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong. PharmacoEconomics - Open. 4(2). 235–247. 21 indexed citations
14.
15.
Shanmugalingam, Renuka, Danny Hsu, & Angela Makris. (2017). Pregnancy-induced atypical haemolytic uremic syndrome: A new era with eculizumab. Obstetric Medicine. 11(1). 28–31. 8 indexed citations
16.
Hsu, Danny, et al.. (2012). Multiple myeloma. BMJ. 344(jan05 1). d7953–d7953. 4 indexed citations
17.
Hsu, Danny, Howard S. Roth, Diana C. West, et al.. (2011). Parallel Synthesis and Biological Evaluation of 837 Analogues of Procaspase-Activating Compound 1 (PAC-1). ACS Combinatorial Science. 14(1). 44–50. 38 indexed citations
18.
Peterson, Quinn P., Danny Hsu, Chris J. Novotny, et al.. (2010). Discovery and Canine Preclinical Assessment of a Nontoxic Procaspase-3–Activating Compound. Cancer Research. 70(18). 7232–7241. 51 indexed citations
19.
Schmit, Joanna, Quinn P. Peterson, Diana C. West, et al.. (2010). Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs. Investigational New Drugs. 29(5). 901–911. 39 indexed citations
20.
Carlier, Paul R., Troy D. Anderson, Dawn M. Wong, et al.. (2008). Towards a species-selective acetylcholinesterase inhibitor to control the mosquito vector of malaria, Anopheles gambiae. Chemico-Biological Interactions. 175(1-3). 368–375. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Labenski Breakdown of academic impact, for papers by Peter D. Gorycki Breakdown of academic impact, for papers by Cunlong Zhang Breakdown of academic impact, for papers by Zilun Hu Breakdown of academic impact, for papers by Zigao Yuan Breakdown of academic impact, for papers by Weiqiong Zuo Breakdown of academic impact, for papers by Lu Zhou Breakdown of academic impact, for papers by Youlu Pan Breakdown of academic impact, for papers by Chiara Rusconi Breakdown of academic impact, for papers by Christophe Henry
Rankless by CCL
2026